Jushi Holdings Inc.

Jushi Holdings Inc. Earnings Recaps

JUSH Healthcare 1 recap
Next earnings: April 21, 2027 (estimated) · full calendar
Q3 2026 Oct 30, 2026

Jushi’s Q3 results showed continued revenue growth and record wholesale sales, alongside slightly lower gross and adjusted EBITDA margins. Shares rose 2.8% after earnings, a broadly neutral reaction that does not signal a decisive market verdict.

Key takeaways
  • Revenue increased 7.3% year over year to $70.5 million, the second consecutive quarter above $70 million.
  • Wholesale revenue rose 40% to a quarterly record $9.7 million; retail revenue grew 3.5% to $60.8 million. Retail units sold rose 8.4%, while lower average selling prices weighed on revenue growth.
  • Gross profit increased to $32.3 million, but gross margin declined about 80 basis points to 45.9%.
  • Adjusted EBITDA rose to $13.6 million, while margin eased to 19.3% from 19.5%. The increase came despite lower employee retention credit income.
  • Virginia retail revenue grew 7.6% year over year to a second consecutive quarterly record as Jushi prepares for adult-use sales scheduled to begin July 1, 2027.